SEC Form 4 · accession 0001209191-16-128382
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John F Crowley
Officer — Chairman & CEO · Director
Period of report
Jun 15, 2016
Accepted (ET)
Jun 17, 2016 · 12:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2016 | A | 41,667 | $0.00 | A | 128,359 | D | |
| Common Stock | holding | — | — | — | 64,895 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $7.93 | Jun 15, 2016 | A | 83,333 | A | — | Jun 15, 2026 | Common Stock | 83,333 | 83,333 | D |
Explanation of responses
- F1These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on June 15, 2017. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on July 1, 2017, with the final installment vesting on June 1, 2020.